Abstract
Stem cells are currently considered to be the best tool for regenerative medicine because of their self-renewal capability and plasticity. It was assumed that the outcomes of cell-based regenerative therapies are achieved due to the engraftment and differentiation of stem cells into targeted cells within the tissues. In recent years, several studies have reported positive outcomes of cell-based therapies despite of insufficient engraftment of transplanted cells. These findings have created a huge interest in the regenerative potential of paracrine factors released from the transplanted stem or progenitor cells. Interestingly, this notion has also led scientists to question the role of proteins in the secretome produced by cells, tissues or organisms under a certain condition or at a particular time for regenerative therapy. Although secretomes can potentially play a vital role in the regeneration process through paracrine signaling, secretome from a particular cell type cannot be the panacea for all diseases. In this review, we attempt to discuss the regenerative potential of secretomes secreted by different cell types for the treatment of different diseases from the molecular point of view. In addition, we also describe the role of pretreatment of cells to produce secretomes enriched with selective paracrine factors that could be designed specifically for a targeted regenerative therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AD-MSC:
-
Adipose tissue-derived MSCs
- AFSCs:
-
Amniotic fluid stem cells
- ALT:
-
Alanine aminotransferase
- AMI:
-
Acute myocardial infarction
- AM-MSCs:
-
Amniotic membrane-derived MSCs
- ANGPTs:
-
Angiopoietins
- AP-MSCs:
-
Apical papilla-derived MSCs
- Apo-PBMC:
-
Apoptotic PBMC
- AST:
-
Aspartate aminotransferase
- BDNF:
-
Brain-derived neurotrophic factor
- BMC:
-
Bone marrow cells
- BM-MSCs:
-
MSCs from bone-marrow
- BMP4:
-
Bone morphogenetic protein 4
- CNS:
-
Central nervous system
- CREB:
-
cAMP response element-binding protein
- DPSCs:
-
Dental pulp-derived MSCs
- EGF:
-
Epidermal growth factor
- eNOS:
-
Endothelial nitric oxide synthase
- Erk1/2:
-
Extracellular-signal regulated kinase
- ESC-MSCs:
-
ESC-derived MSCs
- ESCs:
-
Embryonic stem cells
- FB:
-
Human fibroblasts
- FGF:
-
Fibroblast growth factor
- G-CSF:
-
Granulocyte colony stimulating factor
- GDN:
-
Glia-derived nexin
- GDNF:
-
Glial cell line-derived neurotrophic factor
- GM-CSF:
-
Granulocyte-macrophage colony stimulating factor
- HDF:
-
Human dermal fibroblast
- HGF:
-
Hepatocyte growth factor
- HIF-1a:
-
Hypoxia-inducible factor 1-alpha
- HSP27:
-
Heat shock protein 27
- HUCPVC-MSCs:
-
Human umbilical cord perivascular cell-derived MSCs
- HUVECs:
-
Human umbilical vein epithelial cells
- IFN-γ:
-
Interferon-gamma
- IGF-1:
-
Insulin-like growth factor 1
- IGFBP2:
-
Insulin-like growth factor binding protein 2
- IL:
-
Interleukin
- iNOS:
-
Inducible nitric oxide synthase
- KC:
-
Keratinocytes
- KGF:
-
Keratinocyte growth factor
- LIF:
-
Leukemia inhibitory factor
- LPS:
-
Lipopolysaccharides
- MCP-1:
-
Monocyte chemoattractant protein 1
- M-CSF:
-
Macrophage colony stimulating factor
- MSCs:
-
Mesenchymal stem cells
- OM-MSCs:
-
Olfactory mucosal MSCs
- PBL:
-
Peripheral blood leukocytes
- PBMC:
-
Peripheral blood mononuclear cells
- PCNA:
-
Proliferating cell nuclear antigen
- PDGF-BB:
-
Platelet-derived growth factor beta
- PEDF:
-
Pigment epithelium-derived factor
- SCF:
-
Stem cell factor
- SDF-1:
-
Stromal cell-derived factor-1
- SM-MSCs:
-
Skeletal muscle MSCs
- sTNFR-1:
-
Soluble TNF receptor 1
- TGFβ:
-
Transforming growth factor β
- TNF-α:
-
Tumor necrosis factor alpha
- UT-MSCs:
-
Uterine tubes MSCs
- VEGF-A:
-
Vascular endothelial growth factor A
References
Ahmed NM, Murakami M, Hirose Y, Nakashima M (2016) Therapeutic potential of dental pulp stem cell secretome for Alzheimer’s disease treatment: an in vitro study. Stem Cells Int 2016:8102478. https://doi.org/10.1155/2016/8102478
Ahn H-J, Lee W-J, Kwack K, Kwon YD (2009) FGF2 stimulates the proliferation of human mesenchymal stem cells through the transient activation of JNK signaling. FEBS Lett 583:2922–2926. https://doi.org/10.1016/j.febslet.2009.07.056
Altmann P et al (2014) Secretomes of apoptotic mononuclear cells ameliorate neurological damage in rats with focal ischemia. F1000Res 3:131. https://doi.org/10.12688/f1000research.4219.2
Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276–1312. https://doi.org/10.1101/gad.1653708
Assoni A et al (2017) Different donors mesenchymal stromal cells secretomes reveal heterogeneous profile of relevance for therapeutic use. Stem Cells Dev 26:206–214. https://doi.org/10.1089/scd.2016.0218
Bakopoulou A, About I (2016) Stem cells of dental origin: current research trends and key milestones towards clinical application. Stem Cells Int 2016:4209891. https://doi.org/10.1155/2016/4209891
Bakopoulou A et al (2015) Angiogenic potential and secretome of human apical papilla mesenchymal stem cells in various stress microenvironments. Stem Cells Dev 24:2496–2512. https://doi.org/10.1089/scd.2015.0197
Beegle J, Lakatos K, Kalomoiris S, Stewart H, Isseroff RR, Nolta JA, Fierro FA (2015) Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo. Stem Cells 33:1818–1828. https://doi.org/10.1002/stem.1976
Beegle JR et al (2016) Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia. Mol Ther Methods Clin Dev 3:16053. https://doi.org/10.1038/mtm.2016.53
Beenken A, Mohammadi M (2009) The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8:235–253. https://doi.org/10.1038/nrd2792
Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R (2003) Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287:98–105. https://doi.org/10.1016/S0014-4827(03)00138-1
Bollini S, Gentili C, Tasso R, Cancedda R (2013) The regenerative role of the fetal and adult stem cell secretome. J Clin Med 2:302–327. https://doi.org/10.3390/jcm2040302
Bouchentouf M et al (2010) Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction. Cell Transplant 19:369–386. https://doi.org/10.3727/096368909x484266
Broudy VC (1997) Stem cell factor and hematopoiesis. Blood 90:1345–1364
Burrows GG et al (2013) Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis. Stem Cells Transl Med 2:745–757. https://doi.org/10.5966/sctm.2013-0031
Caplan AI (2013) MSCs as therapeutics. In: Hematti P, Keating A (eds) Mesenchymal stromal cells. Springer, New York, pp 79–90
Christensen K, Doblhammer G, Rau R, Vaupel JW (2009) Ageing populations: the challenges ahead. Lancet 374:1196–1208. https://doi.org/10.1016/S0140-6736(09)61460-4
Correa D et al (2015) Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation. Osteoarthritis Cartilage 23:443–453. https://doi.org/10.1016/j.joca.2014.11.013
Couper KN, Blount DG, Riley EM (2008) IL-10: the master regulator of immunity to infection. J Immunol 180:5771–5777. https://doi.org/10.4049/jimmunol.180.9.5771
Czekanska EM, Ralphs JR, Alini M, Stoddart MJ (2014) Enhancing inflammatory and chemotactic signals to regulate bone regeneration. Eur Cell Mater 28:320–334
Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, Anichini A (2007) Interleukin-12: biological properties and clinical application. Clin Cancer Res 13:4677–4685. https://doi.org/10.1158/1078-0432.CCR-07-0776
Estrada JC et al (2013) Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy. Cell Death Dis 4:e691. https://doi.org/10.1038/cddis.2013.211
Fattori E et al (1994) Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 180:1243–1250. https://doi.org/10.1084/jem.180.4.1243
Fierro F, Illmer T, Jing D, Schleyer E, Ehninger G, Boxberger S, Bornhäuser M (2007) Inhibition of platelet-derived growth factor receptorβ by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro. Cell Prolif 40:355–366. https://doi.org/10.1111/j.1365-2184.2007.00438.x
Forte G et al (2006) Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24:23–33. https://doi.org/10.1634/stemcells.2004-0176
Gabay C (2006) Interleukin-6 and chronic inflammation. Arthritis Res Ther 8:1–6. https://doi.org/10.1186/ar1917
Gaffen SL, Jain R, Garg AV, Cua DJ (2014) The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 14:585–600. https://doi.org/10.1038/nri3707
Galimi F et al (2001) Hepatocyte growth factor is a regulator of monocyte-macrophage function. J Immunol 166:1241–1247
Ge LT et al (2016) Secretome of olfactory mucosa mesenchymal stem cell, a multiple potential stem cell. Stem Cells Int 2016:1243659. https://doi.org/10.1155/2016/1243659
Grasset MF, Gobert-Gosse S, Mouchiroud G, Bourette RP (2010) Macrophage differentiation of myeloid progenitor cells in response to M-CSF is regulated by the dual-specificity phosphatase DUSP5. J Leukoc Biol 87:127–135. https://doi.org/10.1189/jlb.0309151
Haque N, Kasim NH, Rahman MT (2015) Optimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cells. Int J Biol Sci 11:324–334. https://doi.org/10.7150/ijbs.10567
Haque N, Kasim NHA, Kassim NLA, Rahman MT (2017) Autologous serum supplement favours in vitro regenerative paracrine factors synthesis. Cell Prolif 50. https://doi.org/10.1111/cpr.12354
Hathout Y (2007) Approaches to the study of the cell secretome. Expert Rev Proteomics 4:239–248. https://doi.org/10.1586/14789450.4.2.239
He X, Ma J, Jabbari E (2010) Migration of marrow stromal cells in response to sustained release of stromal-derived factor-1alpha from poly(lactide ethylene oxide fumarate) hydrogels. Int J Pharm 390:107–116. https://doi.org/10.1016/j.ijpharm.2009.12.063
Herbst RS (2004) Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 59:S21–S26. https://doi.org/10.1016/j.ijrobp.2003.11.041
Hoetzenecker K et al (2012) Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation. Basic Res Cardiol 107:292. https://doi.org/10.1007/s00395-012-0292-2
Hoetzenecker K et al (2013) Mononuclear cell secretome protects from experimental autoimmune myocarditis. Eur Heart J 36:ehs459. https://doi.org/10.1093/eurheartj/ehs459
Howse K (2006) Increasing life expectancy and the compression of morbidity: a critical review of the debate. Oxford Institute of Population Ageing, Oxford
Hu F, Wang X, Liang G, Lv L, Zhu Y, Sun B, Xiao Z (2013) Effects of epidermal growth factor and basic fibroblast growth factor on the proliferation and osteogenic and neural differentiation of adipose-derived stem cells. Cell Reprogram 15:224–232. https://doi.org/10.1089/cell.2012.0077
Jenniskens YM et al (2006) Biochemical and functional modulation of the cartilage collagen network by IGF1, TGFβ2 and FGF2. Osteoarthritis Cartilage 14:1136–1146. https://doi.org/10.1016/j.joca.2006.04.002
Kang YY, Nagy JM, Polak JM, Mantalaris A (2009) Proteomic characterization of the conditioned media produced by the visceral endoderm-like cell lines HepG2 and END2: toward a defined medium for the osteogenic/chondrogenic differentiation of embryonic stem cells. Stem Cells Dev 18:77–91. https://doi.org/10.1089/scd.2008.0026
Kawada H et al (2004) Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104:3581–3587. https://doi.org/10.1182/blood-2004-04-1488
King NM, Perrin J (2014) Ethical issues in stem cell research and therapy. Stem Cell Res Ther 5:85. https://doi.org/10.1186/scrt474
Kolf CM, Cho E, Tuan RS (2007) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:1–10. https://doi.org/10.1186/ar2116
Konala VB, Mamidi MK, Bhonde R, Das AK, Pochampally R, Pal R (2016) The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cell-free regeneration. Cytotherapy 18:13–24. https://doi.org/10.1016/j.jcyt.2015.10.008
Korf-Klingebiel M et al (2008) Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 29:2851–2858. https://doi.org/10.1093/eurheartj/ehn456
Krausgrill B et al (2009) Influence of cell treatment with PDGF-BB and reperfusion on cardiac persistence of mononuclear and mesenchymal bone marrow cells after transplantation into acute myocardial infarction in rats. Cell Transplant 18:847–853. https://doi.org/10.3727/096368909X471134
Lee SC, Jeong HJ, Lee SK, Kim SJ (2016) Hypoxic conditioned medium from human adipose-derived stem cells promotes mouse liver regeneration through JAK/STAT3 signaling. Stem Cells Transl Med 5:816–825. https://doi.org/10.5966/sctm.2015-0191
Leibinger M, Muller A, Gobrecht P, Diekmann H, Andreadaki A, Fischer D (2013) Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation. Cell Death Dis 4:e609. https://doi.org/10.1038/cddis.2013.126
Lennartsson J, Rönnstrand L (2012) Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol Rev 92:1619–1649. https://doi.org/10.1152/physrev.00046.2011
Liao W, Lin JX, Leonard WJ (2011) IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 23:598–604. https://doi.org/10.1016/j.coi.2011.08.003
Lichtenauer M et al (2011) Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic Res Cardiol 106:1283–1297. https://doi.org/10.1007/s00395-011-0224-6
Lindvall O, Kokaia Z (2010) Stem cells in human neurodegenerative disorders — time for clinical translation? J Clin Invest 120:29–40. https://doi.org/10.1172/JCI40543
Lo B, Parham L (2009) Ethical issues in stem cell research. Endocr Rev 30:204–213. https://doi.org/10.1210/er.2008-0031
Lotfinia M et al (2016) Effect of secreted molecules of human embryonic stem cell-derived mesenchymal stem cells on acute hepatic failure model. Stem Cells Dev 25:1898–1908. https://doi.org/10.1089/scd.2016.0244
Lu B, Nagappan G, Guan X, Nathan PJ, Wren P (2013) BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci 14:401–416. https://doi.org/10.1038/nrn3505
Madrigal M, Rao K, Riordan N (2014) A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med 12:260. https://doi.org/10.1186/s12967-014-0260-8
Malliaras K, Marban E (2011) Cardiac cell therapy: where we’ve been, where we are, and where we should be headed. Br Med Bull 98:161–185. https://doi.org/10.1093/bmb/ldr018
Maraldi T, Beretti F, Guida M, Zavatti M, De Pol A (2015) Role of hepatocyte growth factor in the immunomodulation potential of amniotic fluid stem cells. Stem Cells Transl Med 4:539–547. https://doi.org/10.5966/sctm.2014-0266
Marfia G et al (2016) The adipose mesenchymal stem cell secretome inhibits inflammatory responses of microglia: evidence for an involvement of sphingosine-1-phosphate signalling. Stem Cells Dev 25:1095–1107. https://doi.org/10.1089/scd.2015.0268
Metcalf D (2003) The unsolved enigmas of leukemia inhibitory factor. Stem Cells 21:5–14. https://doi.org/10.1634/stemcells.21-1-5
Mildner M et al (2013) Secretome of peripheral blood mononuclear cells enhances wound healing. PLoS One 8:e60103. https://doi.org/10.1371/journal.pone.0060103
Mirabella T, Hartinger J, Lorandi C, Gentili C, van Griensven M, Cancedda R (2012) Proangiogenic soluble factors from amniotic fluid stem cells mediate the recruitment of endothelial progenitors in a model of ischemic fasciocutaneous flap. Stem Cells Dev 21:2179–2188. https://doi.org/10.1089/scd.2011.0639
Miranda JP et al (2015) The human umbilical cord tissue-derived msc population UCX (R) promotes early motogenic effects on keratinocytes and fibroblasts and G-CSF-mediated mobilization of BM-MSCs when transplanted in vivo. Cell Transplant 24:865–877. https://doi.org/10.3727/096368913x676231
Monteggia LM et al (2004) Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci U S A 101:10827–10832. https://doi.org/10.1073/pnas.0402141101
Moon C, Yoo JY, Matarazzo V, Sung YK, Kim EJ, Ronnett GV (2002) Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation. Proc Natl Acad Sci U S A 99:9015–9020. https://doi.org/10.1073/pnas.132131699
Murakami M et al (2013) The use of granulocyte-colony stimulating factor induced mobilization for isolation of dental pulp stem cells with high regenerative potential. Biomaterials 34:9036–9047. https://doi.org/10.1016/j.biomaterials.2013.08.011
Murphy JW, Cho Y, Sachpatzidis A, Fan C, Hodsdon ME, Lolis E (2007) Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. J Biol Chem 282:10018–10027. https://doi.org/10.1074/jbc.M608796200
Newman AC et al (2013) Analysis of stromal cell secretomes reveals a critical role for stromal cell-derived hepatocyte growth factor and fibronectin in angiogenesis. Arterioscler Thromb Vasc Biol 33:513–522. https://doi.org/10.1161/ATVBAHA.112.300782
Nitsche A, Junghahn I, Thulke S, Aumann J, Radonic A, Fichtner I, Siegert W (2003) Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice. Stem Cells 21:236–244. https://doi.org/10.1634/stemcells.21-2-236
Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R (2011) Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res 6:215–225. https://doi.org/10.1016/j.scr.2011.01.004
Pan S et al (2013) SCF promotes dental pulp progenitor migration, neovascularization, and collagen remodeling - potential applications as a homing factor in dental pulp regeneration. Stem Cell Rev 9:655–667. https://doi.org/10.1007/s12015-013-9442-7
Paquet J, Deschepper M, Moya A, Logeart-Avramoglou D, Boisson-Vidal C, Petite H (2015) Oxygen tension regulates human mesenchymal stem cell paracrine functions. Stem Cells Transl Med 4:809–821. https://doi.org/10.5966/sctm.2014-0180
Pfeffer K (2003) Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 14:185–191
Pianta S, Signoroni PB, Muradore I, Rodrigues MF, Rossi D, Silini A, Parolini O (2015) Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward treg and downregulate Th1 and Th17 cells subsets. Stem Cell Rev Rep 11:394–407. https://doi.org/10.1007/s12015-014-9558-4
Pierson W, Liston A (2010) A new role for interleukin-10 in immune regulation. Immunol Cell Biol 88:769–770. https://doi.org/10.1038/icb.2010.105
Pires AO, Neves-Carvalho A, Sousa N, Salgado AJ (2014) The secretome of bone marrow and wharton jelly derived mesenchymal stem cells induces differentiation and neurite outgrowth in SH-SY5Y cells. Stem Cells Int 2014:438352. https://doi.org/10.1155/2014/438352
Pons J et al (2008) VEGF improves survival of mesenchymal stem cells in infarcted hearts. Biochem Biophys Res Commun 376:419–422. https://doi.org/10.1016/j.bbrc.2008.09.003
Ratajczak M, Kucia M, Jadczyk T, Greco N, Wojakowski W, Tendera M, Ratajczak J (2012) Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 26:1166–1173
Ribeiro CA, Salgado AJ, Fraga JS, Silva NA, Reis RL, Sousa N (2011) The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures). J Tissue Eng Regen Med 5:668–672. https://doi.org/10.1002/term.365
Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33:145–152. https://doi.org/10.1165/rcmb.2004-0330OC
Rossi D, Pianta S, Magatti M, Sedlmayr P, Parolini O (2012) Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. PLoS One 7:e46956. https://doi.org/10.1371/journal.pone.0046956
Rousset F et al (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A 89:1890–1893. https://doi.org/10.1073/pnas.89.5.1890
Salcedo R et al (1999) Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154:1125–1135
Salgado A et al (2015) Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities. Front Cell Neurosci 9. https://doi.org/10.3389/fncel.2015.00249
Sart S, Liu YJ, Ma T, Li Y (2014) Microenvironment regulation of pluripotent stem cell-derived neural progenitor aggregates by human mesenchymal stem cell secretome. Tissue Eng A 20:2666–2679. https://doi.org/10.1089/ten.tea.2013.0437
Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163–189. https://doi.org/10.1189/jlb.0603252
Shi Y et al (2006) Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don’t know. Cell Res 16:126–133. https://doi.org/10.1038/sj.cr.7310017
Son BR et al (2006) Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24:1254–1264. https://doi.org/10.1634/stemcells.2005-0271
Stoddart MJ, Bara J, Alini M (2015) Cells and secretome--towards endogenous cell re-activation for cartilage repair. Adv Drug Deliv Rev 84:135–145. https://doi.org/10.1016/j.addr.2014.08.007
Sulpice E et al (2009) Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells. Biol Cell 101:525–539. https://doi.org/10.1042/BC20080221
Takebayashi T et al (1995) Hepatocyte growth factor/scatter factor modulates cell motility, proliferation, and proteoglycan synthesis of chondrocytes. J Cell Biol 129:1411–1419
Tamama K, Fan VH, Griffith LG, Blair HC, Wells A (2006) Epidermal growth factor as a candidate for ex vivo expansion of bone marrow–derived mesenchymal stem cells. Stem Cells 24:686–695. https://doi.org/10.1634/stemcells.2005-0176
Tamama K, Kawasaki H, Wells A (2010) Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol 2010:795385. https://doi.org/10.1155/2010/795385
Teixeira FG et al (2015) Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation. Stem Cell Rev Rep 11:288–297. https://doi.org/10.1007/s12015-014-9576-2
Teixeira FG et al (2016) Modulation of the mesenchymal stem cell secretome using computer-controlled bioreactors: impact on neuronal cell proliferation, survival and differentiation. Sci Rep 6:27791. https://doi.org/10.1038/srep27791
Teixeira FG et al (2017) Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson’s disease. Stem Cells Transl Med 6:634–646. https://doi.org/10.5966/sctm.2016-0071
Wang Y et al (2006) Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 92:768–774. https://doi.org/10.1136/hrt.2005.069799
Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835–870. https://doi.org/10.1152/physrev.00031.2002
Yanada S, Ochi M, Kojima K, Sharman P, Yasunaga Y, Hiyama E (2006) Possibility of selection of chondrogenic progenitor cells by telomere length in FGF-2-expanded mesenchymal stromal cells. Cell Prolif 39:575–584. https://doi.org/10.1111/j.1365-2184.2006.00397.x
Yew TL et al (2011) Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation. Cell Transplant 20:693–706. https://doi.org/10.3727/096368910X550198
Yu Q, Liu L, Lin J, Wang Y, Xuan X, Guo Y, Hu S (2015) SDF-1α/CXCR4 axis mediates the migration of mesenchymal stem cells to the hypoxic-ischemic brain lesion in a rat model. Cell J (Yakhteh) 16:440–447
Zhang Y et al (2009) A novel function of granulocyte colony-stimulating factor in mobilization of human hematopoietic progenitor cells. Immunol Cell Biol 87:428–432. https://doi.org/10.1038/icb.2009.9
Acknowledgment
This work was supported by High Impact Research MOHE Grant UM.C/625/1/HIR/MOHE/DENT/01 from the Ministry of Higher Education Malaysia and University of Malaya Research Grant UMRG RP019/13HTM.
Conflicts of Interest: The authors confirm that there are no conflicts of interest related to this study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Haque, N., Abdullah, B.J.J., Kasim, N.H.A. (2018). Secretome: Pharmaceuticals for Cell-Free Regenerative Therapy. In: Pham, P. (eds) Stem Cell Drugs - A New Generation of Biopharmaceuticals. Stem Cells in Clinical Applications. Springer, Cham. https://doi.org/10.1007/978-3-319-99328-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-99328-7_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99327-0
Online ISBN: 978-3-319-99328-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)